[1]Mc Caughan GW, George J.Fibrosis progression in chronic hepatitis Cvirus infection[J].Gut, 2004, 53 (3) ∶318-321.
|
[2]中华肝脏病学会肝纤维化学组.肝纤维化诊断及疗效评估共识[J].中华肝脏病杂志, 2002, 10 (5) ∶327-328.
|
[3]陈杰, 陈新月.肝纤维化诊断研究进展[J].国际流行病学传染病学杂志, 2006, 33 (6) ∶423-415.
|
[4]崔东来, 姚希贤.肝纤维化的血清学检测[J].世界华人消化杂志, 2000, 8 (6) ∶683-685.
|
[5]曾民德, 王泰龄, 王宝恩.肝纤维化诊断及疗效评估共识[J].中华肝脏病杂志, 2002, 10 (5) ∶327-328.
|
[6]Wang TF, Wang SJ, Lee FY, et al.Gallbladder wall thickening in patients with liver cirrhosis[J].J Gaatroenterol Hepatol, 1997, 12 (4) ∶445-449.
|
[7]Macias Rodriguez MA, Renoon Unceta P, Navas Relinque C, et al.Uhrasonography in patients with chronic liver disease, its usefulness in the diagnosis of cirrhosis[J].Rey Esp Enferm Dig, 2003, 95 (4) ∶258-264.
|
[8]Christophe A, Frederic O, Nouri K, et al.Ultrasonographie diagnosis of hepatic fibrosis or cirrhosis[J].J Hepatol, 1999, 30 (4) ∶479484.
|
[9]陆玮, 陆思远.肝纤维化诊断和治疗进展[J].国际消化病杂志, 2006, 26 (1) ∶2-4.
|
[10]Hirata M, Akbar SM, Horiike N, et al.Noninvasive diagnosis of the degress of hepatic fibrosis using ultrasonography in patients with chronic liver disease due to hepatitis virus[J].Eur J Clin Invest, 2001, 31 (6) ∶528-535.
|
[11]Sandrin L, Fourquet B, Hasquenoph JM, et al.Transient elastography:a new noninvasive method for assessment of hepatic fibrosis[J].Ultrasound med biol, 2003, 29 (12) ∶1705-1713.
|
[12]贾继东, 李海.肝脏纤维化基础和临床研究进展[J].中华肝脏病杂志, 2009, 17 (1) ∶5-6.
|
[13]Asbach P, Klatt D, Hamhaber U, et a1.Assessment of liver viscoelasticity using multifrequency MR elastography[J].Magn Reson Med, 2008, 60 (2) ∶373-379.
|
[14]王宝恩.当前肝纤维化研究的若干动向[J].中华肝脏病杂志, 2006, 14 (3) ∶167-168.
|
[15]Forns X, Ampurdanes S, Llover JM, et al.Identification of chronic hepatitis C patients without heoatic fibrosis by a simple predictive model[J].Hepatlogy, 2002, 36 (4pt1) ∶986-992.
|
[16]蒋忠胜, 温小凤.慢性肝病肝纤维化非创伤性诊断模型的研究进展[J].肝脏, 2008, 13 (5) ∶430-433.
|
[17]郑荣琴, 吕明德, 谢仕斌, 等.超声与血清肝纤维化标准物检测评价肝纤维化程度及诊断肝硬化的比较[J].中华超声影像学杂志, 2002, 11 (1) ∶29-32.
|
[18]Obrador BD, Prades MG, Gomez MV, et al.A predictive index for the diagnosis of cirrhosis in hepatitis C based on clinical laboratory, and ultrasound findings[J].Eur J Gastroenterol Hepatol, 2006, 18 (1) ∶57-62.
|
[1] | Yu WANG, Min WANG, Guanhua ZHANG, Fuliang HE, Xiaojuan OU, Jidong JIA. Clinical diagnosis, staging, and therapeutic principles of liver cirrhosis[J]. Journal of Clinical Hepatology, 2021, 37(1): 17-21. doi: 10.3969/j.issn.1001-5256.2021.01.004 |
[2] | Zhao WenShan, Xie Wen. Clinical assessment of the reversal of liver cirrhosis: “Point of return”[J]. Journal of Clinical Hepatology, 2019, 35(4): 724-727. doi: 10.3969/j.issn.1001-5256.2019.04.005 |
[3] | Chen YongPeng, Liang XieEr. Radiological evaluation of the reversal of liver fibrosis and cirrhosis[J]. Journal of Clinical Hepatology, 2019, 35(4): 720-723. doi: 10.3969/j.issn.1001-5256.2019.04.004 |
[4] | Liu TianHui. Serological assessment of the reversal of liver fibrosis and cirrhosis[J]. Journal of Clinical Hepatology, 2019, 35(4): 714-719. doi: 10.3969/j.issn.1001-5256.2019.04.003 |
[5] | Tang ChengWei. Work-up for diagnosis and treatment of liver cirrhosis: convention and development[J]. Journal of Clinical Hepatology, 2016, 32(2): 201-202. doi: 10.3969/j.issn.1001-5256.2016.02.001 |
[6] | Han Tao. Acute-on-chronic liver failure due to bacterial infection in liver cirrhosis: causes and management[J]. Journal of Clinical Hepatology, 2015, 31(9): 1415-1417. doi: 10.3969/j.issn.1001-5256.2015.09.012 |
[7] | Zhang JingWen, Shi YongQuan, Han Ying. Progress in treatment of liver cirrhosis[J]. Journal of Clinical Hepatology, 2015, 31(3): 465-468. doi: 10.3969/j.issn.1001-5256.2015.03.037 |
[8] | Xie WeiFen, Ceng Xin. Controversial problems in management of cirrhotic ascites[J]. Journal of Clinical Hepatology, 2014, 30(7): 601-603. doi: 10.3969/j.issn.1001-5256.2014.07.006 |
[9] | Lu LunGen, Li ZhengHong. Diagnosis and assessment of liver cirrhosis[J]. Journal of Clinical Hepatology, 2014, 30(7): 577-579. doi: 10.3969/j.issn.1001-5256.2014.07.001 |
[10] | Wu JianJin, Yao DingKang. Recent advances in understanding the relations between liver cirrhosis and sleep disorders[J]. Journal of Clinical Hepatology, 2013, 29(5): 397-400. |
[11] | Lu LunGen, Li ZhengHong. Recent research on liver fibrosis and cirrhosis[J]. Journal of Clinical Hepatology, 2013, 29(5): 321-323. |
[12] | Wei SiChen, Zheng GuoQi. Role of adipokine in the pathogenesis of cirrhosis of the liver[J]. Journal of Clinical Hepatology, 2012, 28(1): 78-81. |
[13] | Chen Jing, Liu XiaoYan, Hu JinHua, Duan XueZhang, He WeiPing, Wang HuiFen, Xin ShaoJie. Clinical analysis of 24 cases of congenital hepatic fibrosis[J]. Journal of Clinical Hepatology, 2011, 27(10): 1041-1043. |
[14] | Zhong Wei, Xie WeiFen. New strategy for the treatment of hepatic fibrosis[J]. Journal of Clinical Hepatology, 2011, 27(3): 233-235. |
[15] | Cao YuNing, Li SenLin. Research in the progress of non-invasive diagnosis of liver fibrosis[J]. Journal of Clinical Hepatology, 2011, 27(2): 214-217. |
[16] | Qiu Ling, Hu YuLin. Recent status and prospect of ascites treatment in cirrhosis patients[J]. Journal of Clinical Hepatology, 2010, 26(6): 663-665. |
[18] | Li XiaoFeng, Yang XiaoMing, Zhu JianMin, Wang JiXian. The relation between cirrhosis and GERD[J]. Journal of Clinical Hepatology, 2000, 16(4): 243-244. |
[19] | Shang Jia, Wang XiuQi, Jin Xiu, Li YuKui, Li XiuLing. The Targets Hyperfibrinolysis Influence the Prognosis in Cirrhosis Patients[J]. Journal of Clinical Hepatology, 2000, 16(1): 35-36. |